Chaperone therapy for lysosomal and non-lysosomal protein misfolding diseases.

Abstract excerpt

Chaperone therapy was introduced first as a new molecular therapeutic approach to lysosomal diseases. In a recent article, I reviewed the development of chaperone therapy mainly for lysosomal diseases. Then, more data have been collected particularly on non-lysosomal protein misfolding diseases. In this short review, I propose the concept of chaperone therapy to be classified into two different therapeutic...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Lysosomes
• Share to Molecular Chaperones
• Share to Mutation